These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33643180)

  • 1. Association of
    Szwedo AA; Pedersen CC; Ushakova A; Forsgren L; Tysnes OB; Counsell CE; Alves G; Lange J; Macleod AD; Maple-Grødem J
    Front Neurol; 2020; 11():620585. PubMed ID: 33643180
    [No Abstract]   [Full Text] [Related]  

  • 2. SNCA rs356182 variant increases risk of sporadic Parkinson's disease in ethnic Chinese.
    Cheng L; Wang L; Li NN; Yu WJ; Sun XY; Li JY; Zhou D; Peng R
    J Neurol Sci; 2016 Sep; 368():231-4. PubMed ID: 27538639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common variant rs356182 near SNCA defines a Parkinson's disease endophenotype.
    Cooper CA; Jain N; Gallagher MD; Weintraub D; Xie SX; Berlyand Y; Espay AJ; Quinn J; Edwards KL; Montine T; Van Deerlin VM; Trojanowski J; Zabetian CP; Chen-Plotkin AS
    Ann Clin Transl Neurol; 2017 Jan; 4(1):15-25. PubMed ID: 28078311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SNCA rs356219 variant increases risk of sporadic Parkinson's disease in ethnic Chinese.
    Li NN; Mao XY; Chang XL; Zhao DM; Zhang JH; Liao Q; Yu WJ; Tan EK; Peng R
    Am J Med Genet B Neuropsychiatr Genet; 2013 Jul; 162B(5):452-6. PubMed ID: 23737253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variants in SNCA Gene Are Associated with Parkinson's Disease Risk and Cognitive Symptoms in a Brazilian Sample.
    Campêlo CLC; Cagni FC; de Siqueira Figueredo D; Oliveira LG; Silva-Neto AB; Macêdo PT; Santos JR; Izídio GS; Ribeiro AM; de Andrade TG; de Oliveira Godeiro C; Silva RH
    Front Aging Neurosci; 2017; 9():198. PubMed ID: 28676755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SNCA but not DNM3 and GAK modifies age at onset of LRRK2-related Parkinson's disease in Chinese population.
    Yang ZH; Li YS; Shi MM; Yang J; Liu YT; Mao CY; Fan Y; Hu XC; Shi CH; Xu YM
    J Neurol; 2019 Jul; 266(7):1796-1800. PubMed ID: 31041581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SNCA variants and alpha-synuclein level in CD45+ blood cells in Parkinson's disease.
    Emelyanov A; Kulabukhova D; Garaeva L; Senkevich K; Verbitskaya E; Nikolaev M; Andoskin P; Kopytova A; Milyukhina I; Yakimovskii A; Timofeeva A; Prakhova L; Ilves A; Vlasova I; Pchelina S
    J Neurol Sci; 2018 Dec; 395():135-140. PubMed ID: 30316070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variants in the SNCA gene associate with motor progression while variants in the MAPT gene associate with the severity of Parkinson's disease.
    Wang G; Huang Y; Chen W; Chen S; Wang Y; Xiao Q; Liu J; Fung VS; Halliday G; Chen S
    Parkinsonism Relat Disord; 2016 Mar; 24():89-94. PubMed ID: 26776090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of synuclein alpha (
    Chen F; Chen L; Cai G; Wang Y; Li Y; Xu H; Song W; Jian J; Chen X; Ye Q
    Quant Imaging Med Surg; 2024 Sep; 14(9):6806-6819. PubMed ID: 39281177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review of associations between common SNCA variants and clinical heterogeneity in Parkinson's disease.
    Pedersen CC; Lange J; Førland MGG; Macleod AD; Alves G; Maple-Grødem J
    NPJ Parkinsons Dis; 2021 Jul; 7(1):54. PubMed ID: 34210990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α-Synuclein genetic variants predict faster motor symptom progression in idiopathic Parkinson disease.
    Ritz B; Rhodes SL; Bordelon Y; Bronstein J
    PLoS One; 2012; 7(5):e36199. PubMed ID: 22615757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variants in the
    Luo N; Li Y; Niu M; Zhou L; Yao M; Zhu L; Ye G; Kang W; Liu J
    Front Aging Neurosci; 2019; 11():110. PubMed ID: 31244647
    [No Abstract]   [Full Text] [Related]  

  • 13. α-syn and SNP rs356219 as a potential biomarker in blood for Parkinson's disease in Mexican Mestizos.
    Salas-Leal AC; Salas-Pacheco SM; Gavilán-Ceniceros JAP; Castellanos-Juárez FX; Méndez-Hernández EM; La Llave-León O; Camacho-Luis A; Quiñones-Canales G; Romero-Gutiérrez E; Arias-Carrión O; Salas-Pacheco JM; Sandoval-Carrillo AA
    Neurosci Lett; 2021 May; 754():135901. PubMed ID: 33865938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [SNCA rs356219 AND rs356165 VARIANTS ARE ASSOCIATED WITH PARKINSON'S DISEASE AND INCREASED ALPHA-SYNUCLEIN GENE EXPRESSION IN THE CD45(+)-BLOOD CELLS].
    Emelyanov AK; Andoskin PA; Miliukhina IV; Timofeeva AA; Yakimovskii AF; Senkevich KA; Nikolaev MA; Pchelina SN
    Tsitologiia; 2016; 58(2):99-104. PubMed ID: 27228655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Comprehensive Analysis of the Association Between
    Zhang Y; Shu L; Sun Q; Pan H; Guo J; Tang B
    Front Mol Neurosci; 2018; 11():391. PubMed ID: 30410434
    [No Abstract]   [Full Text] [Related]  

  • 16. Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study.
    Wilson H; Dervenoulas G; Pagano G; Koros C; Yousaf T; Picillo M; Polychronis S; Simitsi A; Giordano B; Chappell Z; Corcoran B; Stamelou M; Gunn RN; Pellecchia MT; Rabiner EA; Barone P; Stefanis L; Politis M
    Lancet Neurol; 2019 Aug; 18(8):748-759. PubMed ID: 31229470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SNCA variant associated with Parkinson disease and plasma alpha-synuclein level.
    Mata IF; Shi M; Agarwal P; Chung KA; Edwards KL; Factor SA; Galasko DR; Ginghina C; Griffith A; Higgins DS; Kay DM; Kim H; Leverenz JB; Quinn JF; Roberts JW; Samii A; Snapinn KW; Tsuang DW; Yearout D; Zhang J; Payami H; Zabetian CP
    Arch Neurol; 2010 Nov; 67(11):1350-6. PubMed ID: 21060011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation.
    Latourelle JC; Beste MT; Hadzi TC; Miller RE; Oppenheim JN; Valko MP; Wuest DM; Church BW; Khalil IG; Hayete B; Venuto CS
    Lancet Neurol; 2017 Nov; 16(11):908-916. PubMed ID: 28958801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of rs356219 and rs3822086 polymorphisms with the risk of Parkinson's disease: A meta-analysis.
    Hou B; Zhang X; Liu Z; Wang J; Xie A
    Neurosci Lett; 2019 Sep; 709():134380. PubMed ID: 31325583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Impact on Clinical Features in Parkinson's Disease: A Study on
    Shu L; Liang D; Pan H; Xu Q; Guo J; Sun Q; Tang B; Yan X
    Parkinsons Dis; 2018; 2018():2754541. PubMed ID: 30631417
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.